Antibiotic use and risk of non-hodgkin lymphomas

International Journal of Cancer

Volumn 131, Issue 7, 2012, Pages

  Rasmussen, M L H ^a   Hjalgrim, H ^a   Molgaard Nielsen D ^a   Wohlfahrt, J ^a   Melbye, M ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

antibiotics; cohort study; epidemiology; non Hodgkin lymphoma

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CANCER REGISTRY; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRESCRIPTION; PRIORITY JOURNAL; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REGISTRIES; RISK; YOUNG ADULT;

EID: 84864492489     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27626     Document Type: Article

References (45)

1. Balkwill F, Mantovani A,. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-45.
2. Hussell T, Isaacson PG, Crabtree JE, et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571-4.
3. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
4. Du MQ, Isaccson PG,. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002; 3: 97-104.
5. Kutting B, Bonsmann G, Metze D, et al. Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 1997; 36: 311-4.
6. Roggero E, Zucca E, Mainetti C, et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000; 31: 263-8.
7. Munksgaard L, Obitz ER, Goodlad JR, et al. Demonstration of B. burgdorferi-DNA in two cases of nodal lymphoma. Leuk Lymphoma 2004; 45: 1721-3.
8. Schollkopf C, Melbye M, Munksgaard L, et al. Borrelia infection and risk of non-Hodgkin lymphoma. Blood 2008; 111: 5524-9.
9. Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239-48.
10. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96: 586-94.
11. Ferreri AJ, Ponzoni M, Guidoboni M, et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005; 23: 5067-73.
12. Ferreri AJ, Ponzoni M, Guidoboni M, et al. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J Natl Cancer Inst 2006; 98: 1375-82.
13. Husain A, Roberts D, Pro B, et al. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer 2007; 110: 809-15.
14. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008; 454: 436-44.
15. Filipovich AH, Mathur A, Kamat D, et al. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992; 52: 5465s-7s.
16. Trofe J, Buell JF, First MR, et al. The role of immunosuppression in lymphoma. Recent Results Cancer Res 2002; 159: 55-66.
17. Grogg KL, Miller RF, Dogan A,. HIV infection and lymphoma. J Clin Pathol 2007; 60: 1365-72.
18. Bernstein L, Ross RK,. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992; 52: 5510s-5s.
19. Kato I, Koenig KL, Baptiste MS, et al. History of antibiotic use and risk of non-Hodgkin's lymphoma (NHL). Int J Cancer 2003; 107: 99-105.
20. Chang ET, Smedby KE, Hjalgrim H, et al. Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2005; 162: 965-74.
21. Selby JV, Friedman GD, Fireman BH,. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res 1989; 49: 5736-47.
22. Anderson LA, Gridley G, Engels EA, et al. Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case-control study. Br J Cancer 2008; 98: 161-4.
23. Landgren O, Rapkin JS, Caporaso NE, et al. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 2007; 109: 2198-201.
24. Anderson LA, Landgren O, Engels EA,. Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol 2009; 147: 444-9.
25. Brown LM, Gridley G, Check D, et al. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111: 3388-94.
26. Gregersen H, Pedersen G, Svendsen N, et al. Multiple myeloma following an episode of community-acquired pneumococcal bacteraemia or meningitis. APMIS 2001; 109: 797-800.
27. Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997; 44: 535-9.
28. IARC. WHO classification of tumours of haematopoietic and lymphoid tissue, 4th edn. Lyon: IARC, 2008.
29. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003; 30: 110-5.
30. Harrel FE,. Regression modeling strategies with applications to linear models, logistic regression, and survival analyses, 1st edn. New York: Springer-Verlag, 2001.
31. Arah OA, Chiba Y, Greenland S,. Bias formulas for external adjustment and sensitivity analysis of unmeasured confounders. Ann Epidemiol 2008; 18: 637-46.
32. Freedman DS, Tolbert PE, Coates R, et al. Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men. Am J Epidemiol 1998; 148: 833-41.
33. Talamini R, Polesel J, Montella M, et al. Smoking and non-Hodgkin lymphoma: case-control study in Italy. Int J Cancer 2005; 115: 606-10.
34. Lu Y, Wang SS, Reynolds P, et al. Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study. Am J Epidemiol 2011; 174: 563-73.
35. Ferreri AJ, Ernberg I, Copie-Bergman C,. Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med 2009; 265: 421-38.
36. Landgren O, Gridley G, Check D, et al. Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol 2007; 139: 791-8.
37. Beiderbeck AB, Holly EA, Sturkenboom MC, et al. Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma. Am J Epidemiol 2003; 157: 510-6.
38. Tsai HT, Caporaso NE, Kyle RA, et al. Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood 2009; 114: 4928-32.
39. Landgren O, Albitar M, Ma W, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 2009; 360: 659-67.
40. Kristinsson SY, Tang M, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica, in press.
41. Smedby KE, Baecklund E, Askling J,. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 2006; 15: 2069-77.
42. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006; 98: 51-60.
43. Blix HS, Hjellvik V, Litleskare I, et al. Cigarette smoking and risk of subsequent use of antibacterials: a follow-up of 365,117 men and women. J Antimicrob Chemother 2011; 66: 2159-67.
44. Alexander DD, Mink PJ, Adami HO, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007; 120: 1-39.
45. Lægemiddelstyrelsen, Medicinal Product Statistics, 2006-2010, Denmark, Copenhagen, Lægemiddelstyrelsen, 2011.